| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 3/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 0/6 |
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | HK$9.05 |
| 52 Week Hoogtepunt | HK$13.30 |
| 52 Week Laag | HK$7.87 |
| Bèta | 0.11 |
| 11 maand verandering | -3.00% |
| 3 maanden verandering | 0.89% |
| 1 Jaar Verandering | 10.37% |
| 33 jaar verandering | 90.93% |
| 5 jaar verandering | -62.29% |
| Verandering sinds IPO | 24.48% |
Recent nieuws en updates
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues
Oct 07
Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?
Sep 19Recent updates
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues
Oct 07Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?
Sep 19YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%
May 29Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?
Apr 23YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce
Mar 01Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%
Mar 01YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't
Jan 03YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt
Sep 25Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?
Nov 25Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?
Mar 23Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?
Oct 29Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden
Apr 13YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially
Mar 23YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.
Mar 13YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?
Feb 20
Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?
Feb 02YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Dec 26Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend
Dec 13What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Nov 30Rendement voor aandeelhouders
| 1558 | HK Pharmaceuticals | HK Markt | |
|---|---|---|---|
| 7D | -1.2% | -7.2% | -1.0% |
| 1Y | 10.4% | -2.9% | 15.0% |
Rendement versus industrie: 1558 exceeded the Hong Kong Pharmaceuticals industry which returned -2.9% over the past year.
Rendement versus markt: 1558 underperformed the Hong Kong Market which returned 15% over the past year.
Prijsvolatiliteit
| 1558 volatility | |
|---|---|
| 1558 Average Weekly Movement | 6.5% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.3% |
Stabiele aandelenkoers: 1558 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatiliteit in de loop van de tijd: 1558's weekly volatility (7%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2001 | 4,891 | Juncai Jiang | www.hec-changjiang.com |
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. ontwikkelt, produceert, verkoopt en verkoopt farmaceutische producten in de therapeutische gebieden van anti-infectie, endocriene en metabolische, en andere ziekten in de Volksrepubliek China. Het bedrijf produceert en verkoopt actieve farmaceutische ingrediënten, doet onderzoek naar en ontwikkelt farmaceutische producten, medische apparatuur en geneesmiddelen, evenals biotechnologie, en biedt marketing- en medische adviesdiensten.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Samenvatting
| 1558 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | HK$7.94b |
| Inkomsten(TTM) | HK$1.81b |
| Inkomsten(TTM) | HK$6.07b |
4.4x
Koers/Winstverhouding1.3x
P/S-verhoudingIs 1558 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 1558 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | CN¥5.54b |
| Kosten van inkomsten | CN¥1.17b |
| Brutowinst | CN¥4.37b |
| Overige uitgaven | CN¥2.72b |
| Inkomsten | CN¥1.65b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 1.87 |
| Brutomarge | 78.90% |
| Nettowinstmarge | 29.74% |
| Schuld/Eigen Vermogen Verhouding | 23.9% |
Hoe presteerde 1558 op de lange termijn?
Bekijk historische prestaties en vergelijking